Wednesday, July 8, 2026

biotech · Oculopharyngeal Muscular Dystrophy · Head and Neck Squamous Cell Carcinoma · BNTC

Benitec Biopharma

Benitec Biopharma patent portfolio — 13 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Hayward, USA HQ
2001 Founded
27 Employees
Public company Type
BNTC · NYSE Ticker
Company details
Status
Public
HQ
Hayward, USA
Founded
2001
Employees
27
Programs
2
Drugs
3
Patents
13
Intelligence · Patents

Benitec Biopharma patents

13 pharmaceutical patents indexed for Benitec Biopharma. 0 expire within 24 months.

Benitec Biopharma has 13 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11932852

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11535851

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11234994

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11142765

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 10898505

    Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 10000753

    Age-related macular degeneration treatment

    Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9518260

    Pain treatment

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9410154

    HBV treatment

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 9080174

    HBV treatment

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 8691967

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 8283461

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 8129510

    Minigene expression cassette

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7727970

    Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Benitec Biopharma have?

13 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Benitec Biopharma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.